Clinical Study
Evaluation of Reirradiation in Locally Advanced Head and Neck Cancers: Toxicity and Early Clinical Outcomes
Table 1
Treatment characteristics for the first course of radiotherapy.
| Patient characteristic | | Percent |
| Gender | | | Men | 17 | 85% | Women | 3 | 15% | Primary diagnosis | | | Anterior tongue | 3 | 15% | Base of tongue | 3 | 15% | Retromolar trigone | 2 | 10% | Maxilla | 3 | 15% | Nasal cavity | 3 | 15% | Larynx | 3 | 15% | Hypopharynx | 2 | 10% | CUP | 1 | 5% | Stage | | | I | 4 | 20% | II | 8 | 40% | III | 7 | 35% | IV | 1 | 5% | Treatment | | | RT alone | 18 | 90% | CTRT | 2 | 10% | RT dose (mean ± SD Gy) | | | (Range 45–66 Gy) | | BED3 (mean ± SD Gy) | | |
|
|
CUP, carcinoma with unknown primary; CTRT, chemoradiotherapy; BED3, biologically effective dose for α/β value 3; SD, standard deviation.
|